AIMT

10 Best Stocks for 2020: Megatrends Support This Year’s Biggest Winners

By Sarah Smith, Editor-in-Chief, InvestorPlace.com
Investors don't need a crystal ball to see how major trends in sectors such as e-commerce and biotech are supporting the best stocks in 2020.

Best Stocks for 2020: Aimmune Therapeutics Gets Picked Up for a Steal

By InvestorPlace Research Staff
Nestle picked my Best Stocks pick up for a steal, but I believe the decade of biotechnology is just now getting started.

Aimmune Therapeutics News: Why AIMT Stock Is Skyrocketing Today

By Nick Clarkson, Web Editor
Aimmune Therapeutics' news of its agreement with Nestle regarding its food allergy treatment has AIMT stock soaring way higher on Monday.

10 Best Stocks for 2020: Don’t Take Your Seat Belt Off Just Yet

By Sarah Smith, Editor-in-Chief, InvestorPlace.com
How will InvestorPlace.com's Best Stocks for 2020 contest end? Your guess is as good as mine, but Q3 will be an interesting one to watch.

Best Stocks for 2020: Expect Aimmune Stock to Come Back in Full Force

By InvestorPlace Research Staff
Aimmune Therapeutics may be struggling now in the Best Stocks contest, but the future is still bright for AIMT stock thanks to Palforzia.

10 Best Stocks for 2020: Get Ready for a Roller Coaster Ride in Q2

By Sarah Smith, Editor-in-Chief, InvestorPlace.com
InvestorPlace's Best Stocks for 2020 contest looks dismal after Q1. What will happen with the pandemic, and which stock will win?

Best Stocks for 2020: Aimmune Therapeutics Will Rebound on FDA Approval

By InvestorPlace Research Staff
Aimmune Therapeutics received FDA approval for its Palforzia, so AIMT stock will still be one of the best stocks in 2020.

Aimmune’s Prospects Shine After the FDA Approves Its Allergy Drug

By Chris Lau, InvestorPlace Contributor
Aimmune Therapeutics received FDA approval for its peanut allergy drug Palforzia, and AIMT stock could soar in 2020.

10 Best Stocks for 2020: Buckle Up for a Wild Ride in the Markets

By Sarah Smith, Editor-in-Chief, InvestorPlace.com
Which of our experts will win the best stocks contest? They're all betting on themes likely to dominate in 2020 and beyond.

Best Stocks for 2020: Aimmune’s Allergy Solutions Position It for Huge Success

By InvestorPlace Research Staff
With Palforzia awaiting final FDA approval, 2020 could be a big year for Aimmune Therapeutics. AIMT could be one of the best stocks.

Use Aimmune Therapeutics to Profit off the Rush Into Biotech

By Ken Trester
This morning, I'm recommending a bullish call option on Aimmune Therapeutics, Inc. (NASDAQ:AIMT), the biopharmaceutical company.

5 of the Best Biotech Stocks to Buy Now

By Ian Bezek, InvestorPlace Contributor
Biotech stocks are off to a hot start in 2019, and these five stocks, in particular, could be the next winners.

10 Top Stock Ideas to Beat the Blues

By Harriet Lefton, Writer, TipRanks
These top stock ideas present compelling investing opportunities right now according to the Street's latest reports.

3 Stocks to Watch on Tuesday: Aimmune Therapeutics Inc (AIMT), AnaptysBio Inc (ANAB) and SM Energy Co (SM)

By Karl Utermohlen, InvestorPlace Writer
Aimmune Therapeutics (AIMT), AnaptysBio (ANAB) and SM Energy (SM) all made headlines, with the first two developing peanut allergy medications with encouraging results.